Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Stahel · SciRah

Researcher profile · Semantic Scholar

R. Stahel

Share profile

R. Stahel — researcher profile on SciRah

h-index: 74
Works: 479
Citations: 22K

Most-cited papers

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
M. O'Brien, L. Paz-Ares, S. Marréaud, U. Dafni +17 more
2022The Lancet Oncology583 citations
Semantic Scholar
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.
E. Le Rhun, M. Guckenberger, M. Smits, R. Dummer +17 more
2021Annals of Oncology522 citations Open access
Semantic Scholar
A multicentre randomised phase III trial comparing pembrolizumab vs single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
S. Popat, A. Curioni-Fontecedro, U. Dafni, R. Shah +19 more
2019Annals of Oncology226 citations Open access
Semantic Scholar
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
S. Peters, R. Stahel, L. Bubendorf, P. Bonomi +13 more
2018Clinical Cancer Research213 citations
Semantic Scholar
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review.
S. Kroeze, C. Fritz, M. Høyer, S. Lo +5 more
2017Cancer Treatment Reviews189 citations Open access
Semantic Scholar
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.
R. Rosell, U. Dafni, E. Felip, A. Curioni-Fontecedro +35 more
2017The Lancet Respiratory Medicine184 citations
Semantic Scholar
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
G. Blumenthal, P. Bunn, J. Chaft, C. McCoach +39 more
2018Journal of Thoracic Oncology164 citations Open access
Semantic Scholar
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.
Sanne A. E. Peters, E. Felip, U. Dafni, C. Belka +17 more
2019Lung Cancer157 citations
Semantic Scholar
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).
R. Dziadziuszko, E. Smit, U. Dafni, J. Wolf +11 more
2019Journal of Thoracic Oncology153 citations Open access
Semantic Scholar
PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.
S. Peters, K. Kerr, R. Stahel
2018Cancer Treatment Reviews129 citations Open access
Semantic Scholar
Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy - Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
S. Peters, J. Pujol, U. Dafni, M. Dómine +25 more
2021Annals of Oncology114 citations Open access
Semantic Scholar
Progression-free and overall survival for concurrent nivolumab with standard concurrent chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: Results from the European Thoracic Oncology Platform NICOLAS phase II trial (ETOP 6-14).
S. Peters, E. Felip, U. Dafni, Amanda Tufman +16 more
2020Journal of Thoracic Oncology108 citations Open access
Semantic Scholar
Effectiveness of PD-(L)1 Inhibitors Alone or in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Non-Squamous Non-Small Cell Lung Cancer (nsq-NSCLC) With PD-L1-High Expression Using Real-World Data.
M. Pérol, E. Felip, U. Dafni, L. Polito +7 more
2022Annals of Oncology90 citations Open access
Semantic Scholar
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
L. Bubendorf, U. Dafni, Martin Schöbel, S. Finn +24 more
2017Lung Cancer75 citations Open access
Semantic Scholar
A Novel BRCA1‐Associated Protein‐1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1‐Mediated DNA Repair
R. Parrotta, Agata Okonska, M. Ronner, W. Weder +3 more
2017Journal of Thoracic Oncology58 citations Open access
Semantic Scholar
Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen
M. van Seijen, L. Brčić, A. N. Gonzales, I. Sansano +8 more
2019Virchows Archiv55 citations Open access
Semantic Scholar
Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project.
S. Finn, A. Addeo, U. Dafni, E. Thunnissen +20 more
2021Journal of Thoracic Oncology53 citations Open access
Semantic Scholar
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.
K. Kerr, E. Thunnissen, U. Dafni, S. Finn +32 more
2019Lung Cancer50 citations Open access
Semantic Scholar
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients
Paulino Tallón de Lara, Virginia Cecconi, S. Hiltbrunner, H. Yagita +13 more
2018Clinical Cancer Research50 citations Open access
Semantic Scholar
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial
N. Girard, S. Aix, S. Cedres, T. Berghmans +14 more
2023ESMO Open46 citations Open access
Semantic Scholar
A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells
A. Curioni, C. Britschgi, S. Hiltbrunner, L. Bankel +10 more
2019Annals of Oncology45 citations Open access
Semantic Scholar
A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC - the ETOP and EORTC SPLENDOUR trial.
S. Peters, S. Danson, B. Hasan, U. Dafni +34 more
2020Journal of Thoracic Oncology40 citations Open access
Semantic Scholar
Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients.
Arthur Kostron, M. Friess, I. Inci, S. Hillinger +6 more
2017Interactive Cardiovascular and Thoracic Surgery31 citations Open access
Semantic Scholar
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First‐Line Platinum‐Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS‐lung Trial
S. Peters, R. Stahel, U. Dafni, S. Ponce Aix +38 more
2017Journal of Thoracic Oncology30 citations Open access
Semantic Scholar
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
S. Peters, S. Danson, B. Hasan, U. Dafni +34 more
202028 citations Open access
Semantic Scholar
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
E. Thunnissen, K. Kerr, U. Dafni, L. Bubendorf +19 more
2019Modern Pathology28 citations Open access
Semantic Scholar
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long‐Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)
M. Früh, D. Betticher, R. Stupp, A. Xyrafas +17 more
2019Journal of Thoracic Oncology24 citations Open access
Semantic Scholar
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.
K. Furrer, W. Weder, E. Eboulet, D. Betticher +14 more
2022Journal of Thoracic and Cardiovascular Surgery23 citations
Semantic Scholar
Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition
Agata Okonska, Saskja Bühler, Vasundhara Rao, M. Ronner +11 more
2019Molecular Cancer Therapeutics23 citations Open access
Semantic Scholar
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial.
S. Peters, D. D. De Ruysscher, U. Dafni, E. Felip +15 more
201823 citations
Semantic Scholar
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.
F. Wolpert, M. Weller, A. Berghoff, E. Rushing +15 more
2018European Journal of Cancer22 citations Open access
Semantic Scholar
EORTC-1416-LCG/ETOP 8-15 – PEARLS/KEYNOTE-091 study of pembrolizumab versus placebo for completely resected early-stage non-small cell lung cancer (NSCLC): Outcomes in subgroups related to surgery, disease burden, and adjuvant chemotherapy use.
M. O'Brien, L. Paz-Ares, N. Jha, U. Dafni +16 more
2022Journal of Clinical Oncology20 citations
Semantic Scholar
Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.
I. Opitz, O. Lauk, M. Meerang, A. Jetter +5 more
2019Journal of Thoracic and Cardiovascular Surgery18 citations Open access
Semantic Scholar
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression
K. Oehl, Jelena Kresoja-Rakic, I. Opitz, B. Vrugt +4 more
2018Frontiers in Oncology17 citations Open access
Semantic Scholar
Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
A. Negrouk, D. Lacombe, F. Cardoso, F. Morin +6 more
2017ESMO Open17 citations Open access
Semantic Scholar
European Epidemiology of Pleural Mesothelioma - Real-life data from a joint analysis of the Mesoscape database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma database.
I. Opitz, A. Billè, U. Dafni, K. Nackaerts +26 more
2023Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
VP2-2021: Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data
S. Peters, U. Dafni, M. Pérol, E. Felip +6 more
202115 citations Open access
Semantic Scholar
Evolution and clinical impact of EGFR mutations in circulating free DNA in the BELIEF trial.
M. Molina-Vila, R. Stahel, U. Dafni, N. Jordana-Ariza +22 more
2019Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery
Jelena Kresoja-Rakic, A. Szpechcinski, M. Kirschner, M. Ronner +8 more
2019Non-Coding RNA15 citations Open access
Semantic Scholar
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
C. Schröder, I. Opitz, M. Guckenberger, R. Stahel +4 more
2019Frontiers in Oncology14 citations Open access
Semantic Scholar
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small‐cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
O. Gautschi, S. Rothschild, Qi-Yu Li, K. Matter-Walstra +14 more
2017Clinical Lung Cancer12 citations Open access
Semantic Scholar
Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma.
M. Gachechiladze, J. Škarda, D. Skanderová, I. Überall +12 more
2020Lung Cancer11 citations Open access
Semantic Scholar
Changing the education paradigm in oncology: ESO masterclass, 17 years of continuous success.
N. Pavlidis, F. Peccatori, M. Aapro, C. Rolfo +5 more
2019Critical reviews in oncology/hematology11 citations
Semantic Scholar
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
O. Riesterer, I. Ciernik, R. Stahel, A. Xyrafas +9 more
2019Radiotherapy and Oncology10 citations Open access
Semantic Scholar
Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial
S. Peters, E. Felip, U. Dafni, Amanda Tufman +16 more
2019Annals of Oncology10 citations Open access
Semantic Scholar
Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†.
Arthur Kostron, M. Friess, I. Inci, S. Hillinger +6 more
2017Interactive Cardiovascular and Thoracic Surgery10 citations Open access
Semantic Scholar
Underweight and weight loss are predictors of poor outcome in patients with brain metastasis
Anna Lareida, R. Terziev, Bettina Grossenbacher, N. Andratschke +7 more
2019Journal of Neuro-Oncology9 citations
Semantic Scholar
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
S. Peters, Sarah J. Danson, Dunson Ejedepang, U. Dafni +18 more
2021Lung Cancer8 citations Open access
Semantic Scholar
Clinical Case Presentation and Discussion During ESO-ESMO Masterclass: a 10-Year Interactive Educational Experience
N. Pavlidis, F. Peccatori, M. Aapro, A. Cervantes +4 more
2020Journal of Cancer Education8 citations
Semantic Scholar
Computer‐Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort
U. Rulle, Z. Tsourti, R. Casanova, Karl‐Friedrich Deml +31 more
2018Journal of Thoracic Oncology8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Dafni×23
Invite
U. Dafni — researcher profile on SciRah
S. Peters×20
Invite
S. Peters — researcher profile on SciRah
W. Weder×16
Invite
W. Weder — researcher profile on SciRah
H. Roschitzki-Voser×11
Invite
H. Roschitzki-Voser — researcher profile on SciRah

×10

Invite

M. Pless — researcher profile on SciRah

Invite

Z. Tsourti — researcher profile on SciRah

A. Curioni-Fontecedro×9

Invite

A. Curioni-Fontecedro — researcher profile on SciRah

Invite

E. Felip — researcher profile on SciRah

Invite

R. Kammler — researcher profile on SciRah

Invite

I. Opitz — researcher profile on SciRah

Invite

O. Gautschi — researcher profile on SciRah

M. Guckenberger×7

Invite

M. Guckenberger — researcher profile on SciRah